Design, synthesis and biological evaluation of thienopyrimidine hydroxamic acid based derivatives as structurally novel histone deacetylase (HDAC) inhibitors-Reference-Cited by-同舟云学术

Design, synthesis and biological evaluation of thienopyrimidine hydroxamic acid based derivatives as structurally novel histone deacetylase (HDAC) inhibitors

Published:2017-03 Issue: Volume:128 Page:293-299
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Wang Jiang,Su Mingbo,Li Tingting,Gao Anhui,Yang Wei,Sheng Li,Zang Yi,Li Jia,Liu Hong

Funder

National Natural Science Foundation of China

Major Project of Chinese National Programs for Fundamental Research and Development

National S&T Major Projects

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference23 articles.

1. Histone modifications as molecular targets in nasopharyngeal cancer;Shyamasundar;Curr. Med. Chem.,2016

2. Impact of epigenetic dietary components on cancer through histone modifications;Gao;Curr. Med. Chem.,2015

3. Recent advances in computer-assisted structure-based identification and design of histone deacetylases inhibitors;Krishna;Curr. Top. Med. Chem.,2016

4. Inside HDACs with more selective HDAC inhibitors;Roche;Eur. J. Med. Chem.,2016

5. Histone deacetylase in carcinogenesis and its inhibitors as anti-cancer agents;Kim;J. Biochem. Mol. Biol.,2003

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Emerging therapeutic strategies in cancer therapy by HDAC inhibition as the chemotherapeutic potent and epigenetic regulator;Medical Oncology;2024-03-05

2. Advancements in the diagnosis, prognosis, and treatment of retinoblastoma;Canadian Journal of Ophthalmology;2024-02

3. Suberoylanilide Hydroxamic Acid Analogs with Heteroaryl Amide Group and Different Chain Length: Synthesis and Effect on Histone Deacetylase;Molecules;2024-01-01

4. Recent updates on thienopyrimidine derivatives as anticancer agents;Medicinal Chemistry Research;2023-03-02

5. Recent Progress in Histone Deacetylase (HDAC) 1 Inhibitors as Anticancer Agent;Current Cancer Drug Targets;2023-01